The Priority Review

Clinical trials Brief

PT Bio Farma registers Phase 3 trial of in-house recombinant Hepatitis B vaccine at birth dose

This study was first posted on ClinicalTrials.gov on October 2, 2026. The trial plans to enroll 270 participants and has a planned start date of October 2026 with a planned primary completion date of February 2027.

Primary source

ClinicalTrials.gov registry record, October 2, 2026

Study Interchangeability Hep-B Vaccine Administered at Birth Dose

Read the source clinicaltrials.gov

By The Priority Review desk. Machine-summarized from the source above; not independently reported. How we use automation